About Creoptix
Creoptix is a company based in Wadenswil (Switzerland) founded in 2009 was acquired by Malvern Panalytical in January 2022. Creoptix has raised $11.33 million across 2 funding rounds from investors including Zurcher Kantonalbank, Waters Corporation and Malvern Panalytical. Creoptix operates in a competitive market with competitors including DermaSensor, Cellix, ForteBio, InSilixa and Cortical Labs, among others.
- Headquarter Wadenswil, Switzerland
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.33 M (USD)
in 2 rounds
-
Latest Funding Round
$8.04 M (USD), Series C
Sep 30, 2019
-
Investors
Zurcher Kantonalbank
& 5 more
-
Employee Count
Not available
-
Acquired by
Malvern Panalytical
(Jan 11, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Creoptix
Creoptix has successfully raised a total of $11.33M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $8.04 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Creoptix
Creoptix has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Zurcher Kantonalbank, Waters Corporation and Malvern Panalytical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
StartAngels Network is operated as a non-profit association connecting angel investors with Swiss startups.
|
Locked | Locked | Locked | |
|
Provider of laboratory management system for researchers and clinicians
|
Locked | Locked | Locked | |
|
Swisscanto is recognized as a leading fund manager in Switzerland.
|
Locked | Locked | Locked |
Investor details for Creoptix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Creoptix
Investment portfolio details for Creoptix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Creoptix
Detailed financials for Creoptix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Creoptix Comparisons
Peer comparison for Creoptix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Creoptix
Creoptix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermaSensor, Cellix, ForteBio, InSilixa and Cortical Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Handheld diagnostic device for skin cancer lesions is developed.
|
|
| Locked | Locked | Locked |
Microfluidics, biochips, and high-throughput gene-editing technologies are manufactured.
|
|
| Locked | Locked | Locked |
Real-time biomolecular interactions are analyzed using specialized instruments.
|
|
| Locked | Locked | Locked |
Develops innovative point-of-care diagnostics using semiconductor-based CMOS biochip technology.
|
|
| Locked | Locked | Locked |
Manufacturer of AI-powered biochips
|
Detailed competitors of Creoptix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Creoptix
Complete news archive for Creoptix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Creoptix
Creoptix was founded in 2009 and raised its 1st funding round 4 years after it was founded.
Creoptix is headquartered in Wadenswil, Switzerland. It is registered at Wadenswil, Zurich, Switzerland.
Creoptix is a funded company, having raised a total of $11.33M across 2 funding rounds to date.
Creoptix was founded in 2009 in Wadenswil, Switzerland, within the biotechnology sector. Optical instruments and consumables based on Grating-Coupled Interferometry technology are produced for label-free molecular interaction analysis. Sets for fragment-based screening and binding studies at low concentrations are offered, alongside carboxyl-coupling sensors suitable for various molecules. Software for integrated assay setup and data evaluation is also provided to support these operations.
Creoptix's top competitors include DermaSensor, Cortical Labs and Cellix.
Creoptix has 6 investors. Key investors include Zurcher Kantonalbank, Waters Corporation, Malvern Panalytical, Swisscanto, and StartAngels Network.